Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-22-016509
Filing Date
2022-04-28
Accepted
2022-04-28 17:04:06
Documents
9
Period of Report
2022-06-21

Document Format Files

Seq Description Document Type Size
1 DEF 14A eldn-def14a_20220621.htm DEF 14A 783905
2 GRAPHIC gaamciq2zk44000002.jpg GRAPHIC 7227
3 GRAPHIC gaamciq2zk44000004.jpg GRAPHIC 1611
4 GRAPHIC gaamciq2zk44000005.jpg GRAPHIC 2961
5 GRAPHIC gaamciq2zk44000003.jpg GRAPHIC 2946
6 GRAPHIC gaamciq2zk44000001.jpg GRAPHIC 12973
7 GRAPHIC gaamciq2zk44000008.jpg GRAPHIC 592058
8 GRAPHIC gaamciq2zk44000006.jpg GRAPHIC 3818
9 GRAPHIC gaamciq2zk44000007.jpg GRAPHIC 4399
  Complete submission text file 0001564590-22-016509.txt   1650976
Mailing Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612
Business Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612 949-238-8090
Eledon Pharmaceuticals, Inc. (Filer) CIK: 0001404281 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36620 | Film No.: 22867854
SIC: 2834 Pharmaceutical Preparations